mHealth Intelligence February 14, 2018
Eric Wicklund

The FDA has approved an mHealth app that uses artificial intelligence software to analyze CT scans for signs of a stroke, then sends a text message to a neurologist. The clinical decision support tool could help speed up time to treatment for stroke victims.

Federal regulators have approved an mHealth app that uses artificial intelligence to analyze CT images for signs of a stroke, potentially speeding up the time to treatment.

The U.S. Food and Drug Administration has cleared for marketing the Contact app from Viz.AI, a San Francisco-bases startup that bills its mobile health tool as a direct-to-intervention system. The app uses computer-aided triage software to search for large vessel occlusions in brain CTs, then sends a text message...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Apps, FDA, mHealth
Related Articles:
Syndax Pharmaceuticals Leukemia Drug Wins a First-in-Class FDA Approval
New FDA rules for TV drug ads to take effect: 4 things to know
Artificial heart saves 4th patient
PTC Therapeutics Wins First FDA Approval for a Gene Therapy Dosed Directly Into the Brain
FDA struggles to retain inspectors: GAO

Share This Article